Interleukin-2 induces the growth of human glioblastoma cells in culture

Anticancer Research

Volumn 19, Issue 4 B, 1999, Pages 3147-3151

  Capelli, Enrica ^a   Civallero, Monica ^a   Barni, Sergio ^a   Ceroni, Mauro ^b   Nano, Rosanna ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Center of Study for Histochemistry ^*

Author keywords

Cytochemistry; Electron microscopy; Human glioblastoma cultures; IL 2; IL 2R; Immunocytochemistry

Indexed keywords

ACID PHOSPHATASE; DIHYDROFOLATE REDUCTASE; GROWTH FACTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PEPTIDASE;

ARTICLE; CANCER CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; CYTOCHEMISTRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LYMPHOID CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR GROWTH;

BRAIN NEOPLASMS; CELL DIVISION; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2; MICROSCOPY, ELECTRON; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0033403917     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Strausser JL, Mazumder A, Grimm EA, Lotze ML and Rosenberg SA: Lysis of human solid tumors by autologous cells sensitised in vitro to alloantigens. J Immunol 127: 266-271, 1981.
2. Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE and Matory YL: Observation on the systemic administration of autologous lymphokin activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. New Eng J Med 313: 1485-1492, 1985.
3. Elliot LH , Brooks WH and Roszman TL: Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors. J Immunol 132: 1208-1215, 1984.
4. Kruse CA, Cepeda L. Owens B. Johnson SD, Stears J and Lillehei KO: Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2. Cancer Immunol Immunother 45: 77-87, 1997.
5. Danaila L, Ghyka G and Ursaciue C: Interleukin-2 (IL-2) in the treatment of malignant brain tumors (glioblastoma). Rom J Neurol Psychiatry 31: 195-206, 1993.
6. Vaquero J and Martinez R: Intratumoral immunotherapy with interferon-alpha and interleukin-2 in glioblastoma. Neuroreport 3: 981-983, 1992.
7. Ingram M, Buckwalter JG, Jacques DB, Freshwater DB, Abts RM, Techy GB, Miyagi K, Shelden CH, Rand RW and English LW: Immunotherapy for recurrent malignant glioma: an interim report on survival. Neurol Res 12: 265-273, 1990.
8. Roszman T, Elliott L and Brooks W: Modulation of T-cell function by gliomas. Immunol Today 12: 370-374, 1991.
9. Elliot LH, Brooks WH and Roszman TL: Suppression of high affinity IL-2 receptor on mitogen activated lymphocyte: by glioma-derived suppressor factor. J Neurooncol 14: 1-7, 1992.
10. Flexman J, Manning L and Robinson BWS: in vivo boosting of lung natural killer (NK) and lymphokine activated killer (LAK) cell activity by interleukin-2: comparison of systemic intrapleural and inhalation routes. Clin Immunol Immunopathol 82: 151-156, 1990.
11. Robinson BWS, Manning LS, Bowman RV, Christmas TI, Musk AW, Dawis MR, Bielefeldt Ohmann H, Upham T and Garlepp MJ: The scientific basis for the immunotherapy of human malignant mesothelioma. Eur Respir Rev 3 (11): 195-198, 1993.
12. Swisher SG, Anderson TM, Wen DR, Stene MA, Cochran AJ, Golub SH and Holmes EC: Immunopathological features of human pulmonary tumors following low-dose interleukin-2. Cancer Immunol Immunother 33: 327-332, 1991.
13. Hanisch UK and Quirion R: Interleukin-2 as a neuroregulatory cytokine. Brain Res Rev 21: 246-284, 1995.
14. Otero GC and Merril JE: Response of human oligodendrocytes to interleukin-2. Brain Behav Immun 11: 24-38, 1997.
15. Li CY, Yam LT and Lam KW: Acid phosphatase isoenzyme in human leukocytes in normal and pathologic conditions. J Histochem Cytochem 18: 473-481, 1970.
16. Gerzeli G and De Piceis Polver P: Un nuovo metodo citochimico per lo studio dell'attività tetraidrofolico-reduttasica in Plasmodium berghei: analisi dell'effetto di inibitori specifici. Riv Parassitol 30: 19-22, 1969.
17. Loyda Z: Studie on glycil-prolin-naphthylaminase. Histoch 54: 299-309, 1977.
18. Wagner L, Sunder-Plassmann G, Base W, Wiesholzer M, Sexl V, Lang G and Worman CP: In vivo and in vitro primed lymphocytes correlation of cytochemically detected BTL specific lymphoid serine protein. J Immunol Methods 160: 173-180, 1993.
19. Dexter TM: Lymphokines. In "The Encyclopedia of Molecular Biology" (sir J. Kendrew ed) Blackwell Sci Oxford, pp592-596, 1994.
20. Karnitz LM and Abraham RT: Interleukin-2 receptor signalling mechanisms. Adv Immunol 61: 147-199, 1996.
21. Nano R, Capelli E and Gerzeli G: Morphofunctional characterisation of lymphokine activated killer (LAK) cells in vitro. J Biol Res 71: 181-187, 1995.
22. Capelli E, Nano R, Barni S, Civallero M and Gerzeli G: Selective cell proliferation of lymphocytes induced by different doses of interleukin-2. Eur J Histoch 41: 27, 1997.